Protein recognition of specific DNA-binding sites is critical for the proper biological function of all nucleated cells. Binding specificity is a complex process ultimately dependent upon a protein's ability to complement either directly or indirectly, a DNA sequence. Often, small molecule effectors, which act as environmental sensors, must first bind to the protein to induce conformational changes necessary for specific DNA- binding. Recognizing such environmental signals is crucial for precise transcription regulation and thus requires effector binding to display high specificity. In oligomeric proteins, effector binding is often cooperative. To understand, at the structural level, the mechanism by which environmental signals are interpreted at the level of transcription, we have undertaken crystallographic studies on the E. coli Purine Repressor protein, PurR. Interestingly, the 289 amino acid residue binding domain of the PurR purine effector appears to have its evolutionary origin in the monomeric Periplasmic Binding Domains. Moreover, PurR belongs to a large, structurally conserved, family of oligomeric bacterial gene regulators, the LacI family. The PurR structure will be invaluable to fully understanding the biology of the LacI family, of which none have had their three dimensional structures determined. Therefore, this proposal has several long-term objectives that are designed: to elucidate the structural mechanism by which PurR recognizes a high affinity DNA-binding site; to broaden our understanding of DNA recognition by comparing the PurR-DNA complex to other protein-DNA complexes; to assess the effects of purine-binding on the conformation of PurR; to provide a structural basis to the cooperative nature of purine binding to PurR; and to delineate the structure-function relationships between PurR and the I-ad family as well as the Periplasmic Binding Proteins. To fulfill these long-term objectives, this proposal has four specific aims: (1) to determine the high-resolution crystal structure of the ligand-free Corepressor Binding Domain, CBD, of PurR; (2) to determine the crystal structures of CBD bound to hypoxanthine and guanine; (3) to crystallize and determine the structures of """"""""mutant"""""""" CBD proteins which show diminished corepressor binding; (4) to determine the high-resolution crystal structure of a PurR- Hypoxanthine-purF complex.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM049244-01A2
Application #
2186813
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Project Start
1994-08-01
Project End
1997-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Allen, Gregory S; Steinhauer, Katrin; Hillen, Wolfgang et al. (2003) Crystal structure of HPr kinase/phosphatase from Mycoplasma pneumoniae. J Mol Biol 326:1203-17
Steinhauer, Katrin; Allen, Gregory S; Hillen, Wolfgang et al. (2002) Crystallization, preliminary X-ray analysis and biophysical characterization of HPr kinase/phosphatase of Mycoplasma pneumoniae. Acta Crystallogr D Biol Crystallogr 58:515-8
Huffman, Joy L; Lu, Fu; Zalkin, Howard et al. (2002) Role of residue 147 in the gene regulatory function of the Escherichia coli purine repressor. Biochemistry 41:511-20
Schumacher, Maria A; Pearson, Robert F; Moller, Thorleif et al. (2002) Structures of the pleiotropic translational regulator Hfq and an Hfq-RNA complex: a bacterial Sm-like protein. EMBO J 21:3546-56
Huffman, J L; Mokashi, A; Bachinger, H P et al. (2001) The basic helix-loop-helix domain of the aryl hydrocarbon receptor nuclear transporter (ARNT) can oligomerize and bind E-box DNA specifically. J Biol Chem 276:40537-44
Brown, M; Schumacher, M A; Wiens, G D et al. (2000) The structural basis of repertoire shift in an immune response to phosphocholine. J Exp Med 191:2101-12
Zheleznova, E E; Markham, P N; Neyfakh, A A et al. (1999) Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter. Cell 96:353-62
Glasfeld, A; Koehler, A N; Schumacher, M A et al. (1999) The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions. J Mol Biol 291:347-61
Lu, F; Schumacher, M A; Arvidson, D N et al. (1998) Structure-based redesign of corepressor specificity of the Escherichia coli purine repressor by substitution of residue 190. Biochemistry 37:971-82
Lu, F; Brennan, R G; Zalkin, H (1998) Escherichia coli purine repressor: key residues for the allosteric transition between active and inactive conformations and for interdomain signaling. Biochemistry 37:15680-90

Showing the most recent 10 out of 14 publications